You can narrow down the results using the filters
-
Maawit Maladjiny: Targeting child development in Urban Aboriginal children.
Expand descriptionDespite the high burden of developmental vulnerability in Aboriginal infants, there has been no systematic implementation of early child neurodevelopment programs starting in the first four weeks of life (neonatal period) implemented by primary health care providers. We will be addressing developmental vulnerabilities by implementing the “Care for Child Development” program in Aboriginal and Torres Strait Islander (Aboriginal) children in Perth, Western Australia. Australia has a well-funded and developed universal health care system. Yet, almost 1 in 3 Aboriginal children commence school in Western Australia with at least two developmental vulnerabilities. The ‘Care for Child Development’ (CCD) program, created by WHO and UNICEF, provides an evidence-based, theoretically sound model for improving early child development, parental responsiveness and maternal depression in low and middle-income countries. The CCD program has been implemented in 19 countries and 23 sites, with providers in a range of sectors being able to implement the approach after appropriate training. It combines responsive caregiving and promoting early learning, can be delivered from the first month of life up to 36 months and provides caregivers with practical recommendations on playing, responsive stimulation, caregiver-child interaction, and maternal depression. The most recent effectiveness study of the CCD program in a large, factorial, cluster-randomized trial published in The Lancet Global Health found ‘low intensity’ CCD delivered to infants aged 0-24 months resulted in substantial improvements at 12 and 24 months in cognitive child development compared to the control group. We will undertake a 2-year community-based, randomised effectiveness trial of 400 caregiver-infant pairs with a team of national and international experts. We aim to address the low level of an Aboriginal child’s development attainment by improving primary health care’s capability to deliver world-leading child development services for Aboriginal babies and children. We will do this by determining whether the CCD program delivered through child health checks from the neonatal period will improve caregivers’ abilities to play, communicate and respond to their child’s neurodevelopmental needs throughout the first 24 months of life postpartum.
-
Testing a new model of guided health care for young Aboriginal people to achieve better mental health and emotional wellbeing outcomes
Expand description'Aboriginal’ & 'Indigenous’ are used to respectfully refer to Aboriginal and/ or Torres Strait Islander peoples. We are testing a practical solution to improve engagement of Aboriginal young people with primary care for mental health. Currently <25% of Aboriginal adolescents attend a health clinic to receive a Medicare-funded annual health check. We will compare a new model of health care to standard primary health care to test which best supports the mind, body and spirit of Aboriginal youth. It was developed with Noongar young people, parents/ carers, health workers and Elders in Perth and Bunbury. The new model of care supports the wellbeing of young people in two ways. - A new online health check tool to use before visiting a GP. - A new type of health worker to help young people with their wellbeing needs. This is a specially-trained outreach health support worker role. This health worker supports all the decision made by a young person. They might help with making health appointments, or finding activities to help a young person feel good (like job training or taking part in cultural events). They will have $500 per youth to support wellbeing activities. To be a part of this trial, a person must: – Be an Aboriginal person aged 15 – 24 years – Be living in or near Perth – Have high levels of distress (youth must consent to answer short 10 question tool to measure distress level) A trial research assistant will identify and recruit potential participants via connections with the Aboriginal community, peer group leaders, organisations working with young Aboriginal people and ‘snowball’ sampling of young Indigenous people. For recruitment, trial promotion may include, but is not limited to, the following: brochures, radio, newsletters, websites and private study page on social media. A young person must consent to join the trial before being assigned to a group. Two groups are being compared. A youth is put into a group by random chance, like flipping a coin. Briefly, the: • Intervention group receive guided care though an Outreach Service Navigator in Perth for up to 5 months. They complete an online health check tool which is not the current standard tool used by GPs. A GP at Derbarl Yerrigan Health Service will develop a mental health care plan with the youth based on the new health check. • Waitlist control group receive standard care at Derbarl Yerrigan Health Service in Perth for up to 5 months. The control treatment includes the standard Indigenous health check (Medicare 715) and GP care at DYHS. A GP will develop a mental health care plan with the youth. After the 10 month assessment, a control participant can choose to receive Intervention treatment. At 3 timepoints, participants complete assessments (baseline, 5 months & 10 months). Baseline is after consent and before randomisation. Assessments will measure level of distress, quality of life, social factors, use of health services, work/ study and government support.
-
A comparison of the effectiveness of mindfulness training and computerized working memory training in improving working memory performance of healthy adults in the age range between 18 and 55 years
Expand descriptionParticipants are asked to fill in 4 online questionnaires of memory, mindfulness, attention, mood and mind-wandering, and complete two online tasks of working memory and reasoning ability prior to training. Participants are asked to complete similar tests after the training is completed. After completing baseline measures, participants are then randomly assigned to either of the training groups (mindfulness training or computerised working memory training). Working memory training group is our intervention group and participants in this group will complete their training from the DREAM website by playing CrushStations game. The game is based on the principles of n-back task, a measure of working memory capacity popularly used in working memory training research. Different types and colors of ocean animals will be displayed on participant's screen, and at a later recall test, participants will be asked to recall and remember types and colors of ocean animals. Group 2 is our active control group where participants will complete mindfulness training via the Mindfulness Coach Explorer app. Participants will practice open monitoring and focused attention types of meditation during their training. Both groups will train for 21 minutes in each sitting, for 4 days a week and for 6 weeks altogether. It is hypothesised that working memory training group will show improved performance at post-test on the measures of working memory and reasoning ability, whereas mindfulness training group will show improved performance on the measures of mood, mind-wandering, and mindfulness trait.
-
RISE SAFELY in rural Australia - Redesigning maternity services for Aboriginal mothers and babies who are accessing care at Waminda South Coast Women’s Health and Wellbeing Aboriginal Corporation in Nowra, New South Wales, using Birthing on Country principles and the RISE implementation Framework, to address preterm birth and health outcomes: A prospective, non-randomised, intervention trial.
Expand descriptionThis study aims to establish and evaluate Australia’s ‘Birthing on Country’ rural demonstration site at Waminda South Coast Women’s Health and Wellbeing Aboriginal Corporation in Nowra, New South Wales (Waminda), Yuin Lands. A redesign of the health service will increase continuity and quality of maternity care, and positively impact the health and wellbeing of Aboriginal and Torres Strait Islander (referred to hereafter as Aboriginal in accordance with Waminda’s wishes) women and babies who are accessing care at Waminda. The clinical safety and cost effectiveness of the new service will be systematically evaluated. This project has strong Aboriginal governance, agency and leadership.
-
A randomized controlled trial of Cognitive Processing Therapy for 18-35-year-olds with co-occurring post-traumatic stress and substance use disorders.
Expand descriptionThere are disproportionately higher rates of lifetime trauma and Post-traumatic Stress Disorder (PTSD) among people with substance use disorders (SUDs), which can both precede, and occur as a consequence of substance use. Cognitive Processing Therapy (CPT) is a ‘gold-standard’ PTSD treatment, with a strong emphasis on processing and restructuring maladaptive beliefs around a traumatic event without employing exposure-based strategies. However, the effectiveness of CPT for individuals with co-occurring PTSD and SUD has not been extensively studied. The current project will be a randomized controlled parallel-group trial, which will determine the outcomes of CPT for young people with SUD/PTSD in the residential treatment setting for substance use. Participants will be randomised to receive either TAU or CPT alongside their usual residential treatment (CPT+TAU). Client outcomes on measures of substance use and PTSD, depression, anxiety symptoms will be evaluated at baseline, 1-, 3-, 6-, and 12-months follow-up.
-
A study to evaluate the safety of BW-20829 in subjects with elevated lipoprotein(a)
Expand descriptionThis study is investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single ascending dose of BW-20829 in subjects with elevated lipoprotein(a) in 5 dose level cohorts (up to 3 optional cohorts with 24 subjects may be added). Approximately 40 men and women aged (more than equal to) 18 to (less than equal to) 65 years who fulfill the inclusion and exclusion criteria will be enrolled at sites in Australia. Eligible subjects will be admitted to the clinical research unit on Day -1, dosed on Day 1, discharged on Day 2 (24 hours post-dose), and return for outpatient visits through Day365. Within each cohort, 8 subjects will be randomized in a 3:1 ratio to receive a single dose of BW-20829 (n=6) or placebo (n=2) on Day 1 in a double-blind fashion.
-
A randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics, and immunogenicity of FB102 after single and multiple ascending dose administrations in healthy participants
Expand descriptionThis is a first-in-human, single-centre, randomised, double blind, two-part single and multiple ascending dose study to assess the safety of FB102-101, and how this drug acts in the body in healthy volunteers. FB102-101 may be indicated for use in patients with autoimmune and inflammatory diseases, but a trial of the drug in healthy volunteers is needed before trials in patients with autoimmune and inflammatory diseases can proceed. Who is it for? You may be eligible for this study if you are aged 18 to 60 years and are in good general health without a clinically significant medical history. Study details: All healthy volunteer participants who choose to enrol in this study will be assigned by chance to receive either a single or multiple doses of FB102 or placebo. All participants will have their vital signs checked (heart rate, blood pressure, temperature, etc), and will provide blood and urine samples for testing. The data generated in this study will inform the design of future clinical studies and to select the dose(s) for future studies in patients with autoimmune and inflammatory diseases.
-
Evaluation of wavelet semblance analysis for determining the lower limit of cerebral autoregulation in a non-cardiac surgery population
Expand descriptionThe aim of this study is to evaluate the feasibility of measuring cerebral autoregulation as an individualised metric of hypotension in non-cardiac surgery patients. Specifically, we will translate our novel signal processing techniques to identify the lower limit of cerebral autoregulation. Crucially, translation of this metric will both predict individualised optimal blood pressure targets and act as a target for goal-directed, autoregulation-oriented blood pressure therapy during surgery.
-
Paracetamol and Patent Ductus Arteriosus closure: Pharmacokinetic-Pharmacodynamic study
Expand descriptionPreterm babies are born with a patent ductus arteriosus (PDA), a blood vessel which connects major blood vessels of heart (aorta) and lung (pulmonary artery). PDA can be associated with complications in preterm babies. Therefore, we try to close it with medications, like paracetamol. However, we still don’t succeed in closing a PDA in 30-35% babies. It is possible, that the dose, which we currently provide, may not be enough for some babies. It is still unknown how much paracetamol concentration (level) is needed to achieve a PDA closure. The aim of this study is to measure the concentration and develop a pharmacokinetic-pharmacodynamic (PK-PD) model of paracetamol in preterm babies. This study will enable us to find the appropriate target concentration necessary for PDA closure. We will be able to use this information to vary the dose of paracetamol to achieve higher success rate in preterm babies in future.
-
Impact of occupation-based groups on occupational performance and satisfaction outcomes: pilot study.
Expand descriptionOccupational therapists use a range of rehabilitative approaches to work towards their patients’ goals, one of which is implementing occupation-based interventions. Occupation-based interventions, involve the therapeutic use of engagement in occupation (or an intended daily activity) to achieve change. Delivering occupation-based interventions in the inpatient rehabilitation setting is often time and resource intensive, and the demand for increasing intensity of rehabilitation services poses additional challenges to both clinicians and the health system. Occupational therapists commonly use group-based interventions alongside individual therapy. There are several potential benefits identified by both clinicians and patients for group-based interventions including building connections with co-participants through shared experiences, peer-based learning, and improving motivation for therapy; there are also clear economic benefits as groups can improve time and cost-effectiveness through being able to see more patients at once, as well as offering the potential for a higher intensity of task practice. This study aims to compare the effectiveness of occupation-based groups to occupation-based interventions delivered individually. Occupation-based interventions should be client-cenetred, individualised, and flexible in nature, with the content, intensity and duration of therapy tailored to each patient and their specific occupational performance goals. Thus, further research is warranted to determine whether occupation-based interventions delivered in a group setting using semi-supervised practice can uphold the client-centred nature of this intervention effectively, compared with individual-based delivery. This research will aim to determine the effectiveness of occupation-based groups in adult inpatient rehabilitation and explore the factors impacting on implementation and outcomes of such interventions. It is hypothesized that an occupation-based group intervention will be more effective in improving occupational performance outcomes in adult inpatient rehabilitation compared to usual care.